Clinical Trials Logo

Filter by:
NCT ID: NCT04891120 Completed - Healthy Clinical Trials

Treadmill Stress Test With and Without Mask

TREADMASK
Start date: May 11, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess if wearing a surgical mask affects the results of a standard treadmill test.

NCT ID: NCT04889183 Completed - Obesity Clinical Trials

SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

SMART
Start date: March 14, 2022
Phase: Phase 3
Study type: Interventional

Study to assess the effects of weekly subcutaneous administration of the GLP1-RA semaglutide 2.4mg on kidney function parameters in obese/overweight individuals at high risk of CKD progression.

NCT ID: NCT04888273 Completed - Eating Disorders Clinical Trials

Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services

Start date: May 15, 2021
Phase: N/A
Study type: Interventional

Teenagers with eating disorders often experience a disruption in care upon turning 18. At this age, they are no longer eligible to receive pediatric treatment but are also not yet set up with the appropriate adult services. There are currently no supports in place to help youth with eating disorders and their families during this transition from child to adult care. In this project, the investigators will be implementing an intervention designed to improve this transition experience; it will include peer support, parent education, a meeting with the child and adult care providers, contact with the family doctor, and a written guide about the transition. Among 10 adolescent-parent pairs leaving McMaster Children's Hospital to adult programs in Hamilton, Ontario, the investigators will assess how feasible the intervention is to implement, how feasible the chosen measures are, participants' experience of the intervention, how many adolescents actually transition to adult care, as well as a few adolescent and parent outcomes, such as how prepared the teen feels or what the parents' needs are.

NCT ID: NCT04887883 Completed - Resistance Exercise Clinical Trials

Influence of Sex and Training on de Novo Muscle Protein Synthesis

TUT
Start date: January 1, 2019
Phase:
Study type: Observational

Acute exercise increases the incorporation of dietary amino acids into de novo myofibrillar proteins after a single meal in controlled laboratory studies in males. It is unclear if this extends to free-living settings or is influenced by training or sex. Over 24 h in a free-living setting, the investigators determined the effect of training status and sex on dietary phenylalanine incorporation into contractile myofibrillar and noncontractile sarcoplasmic proteins after exercise.

NCT ID: NCT04887727 Completed - Healthy Adult Males Clinical Trials

Development of Oral Amino Acid Tracers to Study Protein Turnover in Humans

Start date: February 25, 2019
Phase: N/A
Study type: Interventional

Previous studies have used a combination of oral L-[1-13C]leucine and intravenous labeled L-[5,5,5-2H3]leucine to assess the acute postprandial changes in whole-body protein turnover (12, 19). Intravenous and dietary-labeled amino acid tracers have also been used in tandem to assess rates of myofibrillar protein synthesis in response to bolus protein ingestion and resistance exercise (46). By validating whole-body net balance to myofibrillar protein synthesis, our proposed multi-tracer approach will develop minimally invasive models to study protein turnover in a variety of populations in which traditional infusions and/or repeated blood samples are not possible (i.e. pediatric, free-living populations).

NCT ID: NCT04887610 Completed - Dietary Exposure Clinical Trials

Factors That Influence Blood Vessel Regulation During Exercise in Humans

Start date: May 20, 2021
Phase: N/A
Study type: Interventional

This study will examine two separate interventions: 1) the effects of ischemic preconditioning or 2) a high fat meal on the capacity of the brachial artery to overcome sympathetic activation and dilate during exercise (also known as functional sympatholysis). Participants will be asked to complete rhythmic handgrip exercise with and without the application of -20 mmHg lower body negative pressure to increase sympathetic activation. Doppler ultrasound will be used to continuously measure brachial artery blood flow. Participants will complete the handgrip exercise and lower body negative pressure before and after the applications of each interventions. Participants may elect to only complete one intervention rather than complete both protocols. Intervention one is active or control ischemic preconditioning. Intervention two is high or low fat meals.

NCT ID: NCT04886479 Completed - Myopia Clinical Trials

Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers

Start date: March 6, 2019
Phase: N/A
Study type: Interventional

This study was a multi-site, prospective, randomized, non-masked, unilateral, non-dispensing study.

NCT ID: NCT04885907 Completed - Covid19 Clinical Trials

Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

Start date: May 25, 2021
Phase: Phase 4
Study type: Interventional

This study will be a randomized, double-blind, placebo-controlled trial of a third dose of Moderna vaccine versus placebo. Participants will be those that have received two doses of mRNA-1273 COVID vaccine (Moderna) at 0 and 1 months. Participants will be randomized 1:1 to receive either a third dose of the mRNA-1273 vaccine or saline placebo at 3 months post initial vaccination.

NCT ID: NCT04884529 Completed - Dementia Clinical Trials

Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Over 700,000 Canadians are affected by dementia costing the health care system approximately $10 billion/year. Due to COVID-19, the government has urged individuals over the age of 70 to stay home, putting this population at risk of social isolation. Older adults with mild cognitive impairments (MCIs), dementia, and their caregivers are at an even higher risk of becoming stressed, anxious, and agitated while in lockdown. Unsurprisingly, caregiver burden is extremely common, and often precedes institutionalization of the patient, as the demands of the illness begin to exceed that which the caregiver can sustainably provide. Since social distancing measures have shut down activities and support groups for these individuals, there is an urgent need for scalable, cost-effective, non-pharmacological interventions that can be delivered remotely to improve stress and loneliness. Yoga may be a viable therapeutic modality to address the psychological challenges associated with dementia in patients and caregivers, as it has been shown to decrease stress and improve anxiety and depressive symptoms in various populations. For this reason, the investigators are conducting a randomized controlled trial (RCT) to assess the efficacy of an 8-week virtual chair yoga program to improve stress, psychological symptoms, and caregiver burden. This virtual chair yoga study will engage both older adults with dementia/MCI and caregivers (n=40-60 participants) during COVID-19, which is consistent with the need for decreasing costs and increasing accessibility of novel health interventions during and beyond the pandemic. The investigators will evaluate the effect of this program on stress, loneliness, and mental health related outcomes such as fear of COVID-19, depression, anxiety, and caregiver burden compared to a waitlist control group. There will also be a qualitative component in the form of semi-structured interviews. All quantitative outcomes will be assessed before the program starts and post-intervention and qualitative outcomes will be assessed post-intervention. Participants will be randomly assigned to the treatment group (virtual chair yoga 1 hour per week on Zoom) or the waitlist control group. The investigators hypothesize that after the 8-week yoga program, older adults and caregivers will report lower stress, loneliness, depression, anxiety, fear of COVID-19, and caregiver burden. Results will be available late-2021.

NCT ID: NCT04882917 Completed - Clinical trials for Advanced Solid Tumors

First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)

Start date: May 24, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), maximum tolerated dose (MTD) (if reached) and early signs of efficacy of M4076 monotherapy in participants with solid tumors in dose escalation (Part 1A). Once the recommended dose for expansion (RDE) is declared in Part 1A, a preliminary food effect cohort, Part 1B, will follow at the RDE determined from Part 1A.